ReviewPharmaceutics2024

Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy.

Yijiang Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.